Abbott Laboratories (ABT) 39.63 $ABT
Covered Call reports for Apple, SolarCity, Skyworks Solutions, NVIDIA, and Abbott Laboratories include trade ideas that offer returns of 20% or more!
PR Newswire - Thu Jun 23, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for AAPL, ABT, NVDA, SCTY, and SWKS.
ABT: 39.63 (+0.89), SWKS: 67.21 (+1.86), SCTY: 21.98 (+0.10), AAPL: 96.10 (+0.55), NVDA: 48.49 (+1.26)
Abbott Hosts Conference Call for Second-Quarter Earnings
PR Newswire - Wed Jun 22, 8:00AM CDT
Abbott (NYSE: ABT) will announce its second-quarter 2016 financial results on Wednesday, July 20, 2016, before the market opens.
ABT: 39.63 (+0.89)
Epizyme Offers Early Data on Non-Hodgkin Lymphoma Drug
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 2:05PM CDT
Epizyme, Inc. (EPZM) reported encouraging preliminary data from its ongoing, global phase II trial on lead pipeline candidate, tazemetostat, at the American Society of Hematology Meeting on Lymphoma Biology.
ABT: 39.63 (+0.89), PFE: 34.59 (+0.12), EPZM: 10.44 (-0.28), BMY: 72.64 (+0.33)
Global Enteral Feeding Devices Market Growth of 5.5% CAGR by 2021 - Analysis, Technologies & Forecasts Report 2016-2021 - Key Vendors: Abbott Labs, Conmed Corp, Moog - Research and Markets
BusinessWire - Mon Jun 20, 1:31PM CDT
Research and Markets has announced the addition of the "Enteral Feeding Devices Market by Product (Feeding Pump, Feeding Tube, Giving Set, Enteral Syringes), Stage (Adult, Pediatrics), Application (Oncology, Gastroenterology, Neurology), End User (Hospital, Ambulatory Care) - Global Forecast to 2021" report to their offering.
ABT: 39.63 (+0.89), MOG.A: 54.92 (+0.51)
Global Biomarkers Market Worth USD 92.5 Billion by 2025 - Analysis, Technologies & Forecasts Report 2016-2025 - Key Vendors: Abbott Labs, Agilent Technologies, Bio-Rad Labs - Research and Markets
BusinessWire - Fri Jun 17, 3:01PM CDT
Research and Markets has announced the addition of the "Global Biomarkers Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
ABT: 39.63 (+0.89), A: 46.68 (+0.65)
Global Patient Monitoring Devices Market Worth USD 33.9 Billion by 2025 - Analysis, Technologies & Forecasts Report 2016-2025 - Key Vendors: Abbott Labs, Omron Healthcare, Masimo Corp - Research and Markets
BusinessWire - Fri Jun 17, 2:40PM CDT
Research and Markets has announced the addition of the "Global Patient Monitoring Devices Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
ABT: 39.63 (+0.89), MASI: 52.38 (+0.69)
Global Microbiology Testing/Clinical Microbiology Market Worth USD 5.77 Billion by 2021 - Analysis, Technologies & Forecasts Report 2016-2021 - Key Vendors: Abbott Labs, Alere, Bio-Rad Labs - Research and Markets
BusinessWire - Fri Jun 17, 12:43PM CDT
Research and Markets has announced the addition of the "Microbiology Testing/Clinical Microbiology Market by Microbiology Application, Clinical Application, Product - Global Forecasts to 2021" report to their offering.
ABT: 39.63 (+0.89)
Abbott Laboratories (ABT) Is in Oversold Territory: What's Next?
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 7:58AM CDT
Abbott Laboratories (ABT) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
ABT: 39.63 (+0.89)
Aegerion, QLT Ink Merger Deal to Form Novelion Therapeutics
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 11:23PM CDT
Aegerion Pharmaceuticals, Inc. (AEGR) announced that it has entered into a definitive merger agreement with QLT Inc. (QLTI).
ABT: 39.63 (+0.89), JNJ: 117.38 (+0.92), QLTI: 1.43 (+0.02), AEGR: 1.67 (+0.11)
Shire Buys Global Rights to Pfizer's Gastrointestinal Drug
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 4:19PM CDT
Shire plc (SHPG) announced that it will license global rights to all indications of Pfizer's candidate, PF-00547659.
ABT: 39.63 (+0.89), JNJ: 117.38 (+0.92), SHPG: 180.29 (+4.91), PFE: 34.59 (+0.12)
Tell Awards Celebrate Leading Corporate Investors in Switzerland
BusinessWire - Wed Jun 15, 3:57PM CDT
Switzerland Global Enterprise, the official trade and investment body of the Swiss government, announced today the winners of the 2016 Tell Awards.
ABT: 39.63 (+0.89)
Novo Nordisk (NVO) Reports Positive Trial Results on Victoza
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 2:17PM CDT
Novo Nordisk (NVO) announced results from the LEADER trial on Victoza at the American Diabetes Association's 76th Scientific Sessions.
ABT: 39.63 (+0.89), NVO: 53.40 (+0.98), PFE: 34.59 (+0.12), BMY: 72.64 (+0.33)
Shire Gets Breakthrough Status for Rare Disease Candidates
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 5:18PM CDT
Shire plc (SHPG) announced that the FDA has granted Breakthrough Therapy Designation to two candidates in its rare diseases pipeline.
ABT: 39.63 (+0.89), SHPG: 180.29 (+4.91), PFE: 34.59 (+0.12), BMY: 72.64 (+0.33)
Abbott Labs (ABT) Reports Positive Data on FreeStyle Libre
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 2:28PM CDT
Abbott Laboratories (ABT) announced positive results from the IMPACT trial on FreeStyle Libre.
ABT: 39.63 (+0.89), ANIP: 56.27 (+3.48), PFE: 34.59 (+0.12), BMY: 72.64 (+0.33)
Dane Bremer of Liberty Mutual Named New Chairperson of NETS
BusinessWire - Mon Jun 13, 8:30AM CDT
The Network of Employers for Traffic Safety (NETS) is pleased to announce the election of Dane Bremer, Director - Corporate Safety & Global Business Continuity for Liberty Mutual, as NETS Board Chairperson for 2016 and 2017. Bremer replaces Joe McKillips, Director, Commercial Program Support for Abbott Laboratories, following a successful two-year term. Liberty Mutual has been a NETS board member company since 1996, with Dane as the representative since 2013.
ABT: 39.63 (+0.89)
Watch for Abbott Laboratories to Potentially Rebound After Falling 1.38% Yesterday
Comtex SmarTrend(R) - Fri Jun 10, 1:08PM CDT
Abbott Laboratories (NYSE:ABT) traded in a range yesterday that spanned from a low of $38.23 to a high of $38.70. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $38.65 on volume of 4.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ABT: 39.63 (+0.89)
India Cardiovascular Devices Market Report 2016-2021 - Analysis, Technologies & Forecasts - Key Vendors: Medtronic, St. Jude Medical, Abbott Labs - Research and Markets
BusinessWire - Fri Jun 10, 12:10PM CDT
Research and Markets has announced the addition of the "India Cardiovascular Devices Market Outlook to 2021 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others" report to their offering.
ABT: 39.63 (+0.89), MDT: 85.77 (+1.51), STJ: 78.49 (+0.82)
Abbott Declares 370th Consecutive Quarterly Dividend
PR Newswire - Fri Jun 10, 10:05AM CDT
The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 26 cents per share.
ABT: 39.63 (+0.89)
7 Medical Stocks to Buy with Market-Beating Yields
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 8:50AM CDT
Medical is one of the very few sectors that generally show great resilience during volatile phases in the market.
KND: 11.59 (+0.24), ABT: 39.63 (+0.89), JNJ: 117.38 (+0.92), PFE: 34.59 (+0.12), BMY: 72.64 (+0.33), HLS: 40.82 (+0.69), DRAD: 5.22 (+0.05)
World Food Intolerance Products Market Worth USD 13.9 Billion by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: Abbott Labs, Danone, Kellogg - Research and Markets
BusinessWire - Thu Jun 09, 8:34AM CDT
Research and Markets has announced the addition of the "World Food Intolerance Products Market - Opportunities & Forecasts, 2015 - 2022" report to their offering.
ABT: 39.63 (+0.89)
Covered Call reports for Apple, SolarCity, Skyworks Solutions, NVIDIA, and Abbott Laboratories include trade ideas that offer returns of 20% or more!
PR Newswire - Thu Jun 23, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for AAPL, ABT, NVDA, SCTY, and SWKS.
ABT: 39.63 (+0.89), SWKS: 67.21 (+1.86), SCTY: 21.98 (+0.10), AAPL: 96.10 (+0.55), NVDA: 48.49 (+1.26)
Abbott Hosts Conference Call for Second-Quarter Earnings
PR Newswire - Wed Jun 22, 8:00AM CDT
Abbott (NYSE: ABT) will announce its second-quarter 2016 financial results on Wednesday, July 20, 2016, before the market opens.
ABT: 39.63 (+0.89)
Epizyme Offers Early Data on Non-Hodgkin Lymphoma Drug
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 2:05PM CDT
Epizyme, Inc. (EPZM) reported encouraging preliminary data from its ongoing, global phase II trial on lead pipeline candidate, tazemetostat, at the American Society of Hematology Meeting on Lymphoma Biology.
ABT: 39.63 (+0.89), PFE: 34.59 (+0.12), EPZM: 10.44 (-0.28), BMY: 72.64 (+0.33)
Global Enteral Feeding Devices Market Growth of 5.5% CAGR by 2021 - Analysis, Technologies & Forecasts Report 2016-2021 - Key Vendors: Abbott Labs, Conmed Corp, Moog - Research and Markets
BusinessWire - Mon Jun 20, 1:31PM CDT
Research and Markets has announced the addition of the "Enteral Feeding Devices Market by Product (Feeding Pump, Feeding Tube, Giving Set, Enteral Syringes), Stage (Adult, Pediatrics), Application (Oncology, Gastroenterology, Neurology), End User (Hospital, Ambulatory Care) - Global Forecast to 2021" report to their offering.
ABT: 39.63 (+0.89), MOG.A: 54.92 (+0.51)
Global Biomarkers Market Worth USD 92.5 Billion by 2025 - Analysis, Technologies & Forecasts Report 2016-2025 - Key Vendors: Abbott Labs, Agilent Technologies, Bio-Rad Labs - Research and Markets
BusinessWire - Fri Jun 17, 3:01PM CDT
Research and Markets has announced the addition of the "Global Biomarkers Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
ABT: 39.63 (+0.89), A: 46.68 (+0.65)
Global Patient Monitoring Devices Market Worth USD 33.9 Billion by 2025 - Analysis, Technologies & Forecasts Report 2016-2025 - Key Vendors: Abbott Labs, Omron Healthcare, Masimo Corp - Research and Markets
BusinessWire - Fri Jun 17, 2:40PM CDT
Research and Markets has announced the addition of the "Global Patient Monitoring Devices Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
ABT: 39.63 (+0.89), MASI: 52.38 (+0.69)
Global Microbiology Testing/Clinical Microbiology Market Worth USD 5.77 Billion by 2021 - Analysis, Technologies & Forecasts Report 2016-2021 - Key Vendors: Abbott Labs, Alere, Bio-Rad Labs - Research and Markets
BusinessWire - Fri Jun 17, 12:43PM CDT
Research and Markets has announced the addition of the "Microbiology Testing/Clinical Microbiology Market by Microbiology Application, Clinical Application, Product - Global Forecasts to 2021" report to their offering.
ABT: 39.63 (+0.89)
Abbott Laboratories (ABT) Is in Oversold Territory: What's Next?
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 7:58AM CDT
Abbott Laboratories (ABT) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
ABT: 39.63 (+0.89)
Aegerion, QLT Ink Merger Deal to Form Novelion Therapeutics
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 11:23PM CDT
Aegerion Pharmaceuticals, Inc. (AEGR) announced that it has entered into a definitive merger agreement with QLT Inc. (QLTI).
ABT: 39.63 (+0.89), JNJ: 117.38 (+0.92), QLTI: 1.43 (+0.02), AEGR: 1.67 (+0.11)
Shire Buys Global Rights to Pfizer's Gastrointestinal Drug
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 4:19PM CDT
Shire plc (SHPG) announced that it will license global rights to all indications of Pfizer's candidate, PF-00547659.
ABT: 39.63 (+0.89), JNJ: 117.38 (+0.92), SHPG: 180.29 (+4.91), PFE: 34.59 (+0.12)
Tell Awards Celebrate Leading Corporate Investors in Switzerland
BusinessWire - Wed Jun 15, 3:57PM CDT
Switzerland Global Enterprise, the official trade and investment body of the Swiss government, announced today the winners of the 2016 Tell Awards.
ABT: 39.63 (+0.89)
Novo Nordisk (NVO) Reports Positive Trial Results on Victoza
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 2:17PM CDT
Novo Nordisk (NVO) announced results from the LEADER trial on Victoza at the American Diabetes Association's 76th Scientific Sessions.
ABT: 39.63 (+0.89), NVO: 53.40 (+0.98), PFE: 34.59 (+0.12), BMY: 72.64 (+0.33)
Shire Gets Breakthrough Status for Rare Disease Candidates
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 5:18PM CDT
Shire plc (SHPG) announced that the FDA has granted Breakthrough Therapy Designation to two candidates in its rare diseases pipeline.
ABT: 39.63 (+0.89), SHPG: 180.29 (+4.91), PFE: 34.59 (+0.12), BMY: 72.64 (+0.33)
Abbott Labs (ABT) Reports Positive Data on FreeStyle Libre
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 2:28PM CDT
Abbott Laboratories (ABT) announced positive results from the IMPACT trial on FreeStyle Libre.
ABT: 39.63 (+0.89), ANIP: 56.27 (+3.48), PFE: 34.59 (+0.12), BMY: 72.64 (+0.33)
Dane Bremer of Liberty Mutual Named New Chairperson of NETS
BusinessWire - Mon Jun 13, 8:30AM CDT
The Network of Employers for Traffic Safety (NETS) is pleased to announce the election of Dane Bremer, Director - Corporate Safety & Global Business Continuity for Liberty Mutual, as NETS Board Chairperson for 2016 and 2017. Bremer replaces Joe McKillips, Director, Commercial Program Support for Abbott Laboratories, following a successful two-year term. Liberty Mutual has been a NETS board member company since 1996, with Dane as the representative since 2013.
ABT: 39.63 (+0.89)
Watch for Abbott Laboratories to Potentially Rebound After Falling 1.38% Yesterday
Comtex SmarTrend(R) - Fri Jun 10, 1:08PM CDT
Abbott Laboratories (NYSE:ABT) traded in a range yesterday that spanned from a low of $38.23 to a high of $38.70. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $38.65 on volume of 4.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ABT: 39.63 (+0.89)
India Cardiovascular Devices Market Report 2016-2021 - Analysis, Technologies & Forecasts - Key Vendors: Medtronic, St. Jude Medical, Abbott Labs - Research and Markets
BusinessWire - Fri Jun 10, 12:10PM CDT
Research and Markets has announced the addition of the "India Cardiovascular Devices Market Outlook to 2021 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others" report to their offering.
ABT: 39.63 (+0.89), MDT: 85.77 (+1.51), STJ: 78.49 (+0.82)
Abbott Declares 370th Consecutive Quarterly Dividend
PR Newswire - Fri Jun 10, 10:05AM CDT
The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 26 cents per share.
ABT: 39.63 (+0.89)
7 Medical Stocks to Buy with Market-Beating Yields
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 8:50AM CDT
Medical is one of the very few sectors that generally show great resilience during volatile phases in the market.
KND: 11.59 (+0.24), ABT: 39.63 (+0.89), JNJ: 117.38 (+0.92), PFE: 34.59 (+0.12), BMY: 72.64 (+0.33), HLS: 40.82 (+0.69), DRAD: 5.22 (+0.05)
World Food Intolerance Products Market Worth USD 13.9 Billion by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: Abbott Labs, Danone, Kellogg - Research and Markets
BusinessWire - Thu Jun 09, 8:34AM CDT
Research and Markets has announced the addition of the "World Food Intolerance Products Market - Opportunities & Forecasts, 2015 - 2022" report to their offering.
ABT: 39.63 (+0.89)
